Software and AI medical device compliance represents one of the most complex and rapidly evolving areas of regulatory science. It requires integration of traditional quality management principles with advanced computational controls, data governance.
Decision-making under uncertainty is a defining challenge for therapeutic goods startups. Companies must determine when to validate, submit, or scale manufacturing while balancing quality requirements, regulatory expectations, and lean operational timelines.
This case study illustrates how targeted ISO 13485 support can enable a SaMD and IVD medical device start-up to establish robust, compliant quality systems and achieve audit readiness.
Establishing readiness for clinical trial manufacturing is a multidimensional process requiring attention to regulatory compliance, facility and personnel preparedness, quality systems, process validation, supply chain management, and risk oversight.